[Radioactive phosphorus uptake test in ophthalmology]

Area of Science:

• Ophthalmology
• Nuclear Medicine
• Oncology

Background:

• Differential diagnosis of intraocular lesions is crucial for appropriate patient management.
• Radioactive phosphorus (P32) uptake testing has been explored as a diagnostic tool in ophthalmology.

Purpose of the Study:

• To evaluate the utility of the radioactive phosphorus uptake test in the differential diagnosis of intraocular lesions.
• To assess the accuracy and limitations of P32 uptake testing in differentiating ocular tumors.

Main Methods:

• The study involved 21 patients with intraocular lesions undergoing radioactive phosphorus uptake testing.
• Testing procedures varied based on lesion location (anterior vs. posterior segment).
• Histological confirmation was obtained for the majority of diagnoses.

Main Results:

• The P32 uptake test demonstrated high positivity in patients with uveal malignant melanoma.
• False-positive results were observed in 3 patients with choroidal hemangioma, showing lower P32 uptake than melanomas.
• One false-negative result occurred in a histologically confirmed uveal malignant melanoma case.

Conclusions:

• Radioactive phosphorus uptake testing is a valuable tool for diagnosing intraocular lesions, particularly uveal melanomas.
• The test has limitations, including potential false positives in conditions like choroidal hemangioma and rare false negatives in malignant melanomas.
• Test methodology may need refinement to improve specificity and reduce false results.